Slideshows Images Quizzes


Last reviewed on RxList: 8/24/2017
Oxecta Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 8/24/2017

Oxecta (oxycodone HCl) is indicated for the management of acute and chronic moderate to severe pain. Common side effects of Oxecta include abdominal pain, nausea, vomiting, constipation, lightheadedness, dizziness, drowsiness, low blood pressure, weakness, itching, accidental injury, allergic reaction, back pain, chills, fever, fever, flu syndrome, infection, neck pain, sensitivity to sunlight, and severe infection (sepsis).

The dose of Oxecta is individually adjusted according to severity of pain, and the patient's response, weight, age, and prior analgesic treatment experience. Oxecta may interact with other central nervous system (CNS) depressants (including sedatives, hypnotics, general anesthetics, antiemetics, phenothiazines, other tranquilizers, and alcohol), skeletal muscle relaxants, pentazocine, nalbuphine, butorphanol, buprenorphine, monoamine oxidase inhibitors (MAOIs), macrolide antibiotics, azole antifungals, protease inhibitors, rifampin, carbamazepine, phenytoin, cardiovascular drugs including amiodarone and quinidine, antidepressants, and anticholinergics. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or become pregnant before using Oxecta. Newborns whose mothers have taken oxycodone chronically may exhibit respiratory depression and/or withdrawal symptoms, either at birth and/or in the nursery. Oxecta passes into breast milk and may cause adverse reactions in a nursing infant. Breastfeeding while using Oxecta is not recommended.

Our Oxecta Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Oxecta Professional Information


Clinical Studies

Because clinical trials are conducted under widely varying conditions, the adverse reaction rates observed in clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.

Serious adverse reactions that may be associated with OXECTA include: respiratory depression, respiratory arrest, circulatory depression, cardiac arrest, hypotension, and/or shock [see WARNINGS AND PRECAUTIONS and OVERDOSAGE].

The common adverse reactions seen on initiation of therapy with OXECTA are dose-dependent, and their frequency depends on the clinical setting, the patient's level of opioid tolerance, and host factors specific to the individual. They should be expected and managed as a part of opioid therapy. The most frequent of the adverse reactions include nausea, constipation, vomiting, headache, and pruritus.

The frequency of adverse reactions during initiation of opioid therapy may be minimized by careful individualization of starting dosage, slow titration and the avoidance of large rapid swings in plasma concentration of the opioid. Many of these adverse reactions will abate as therapy is continued and some degree of tolerance is developed, but others may be expected to remain throughout therapy.

In all patients for whom dosing information was available (n=191) from open-label and double-blind studies involving oxycodone, the following adverse reactions were recorded in oxycodone-treated patients with an incidence of ≥ 3%. In descending order of frequency they were: nausea, constipation, vomiting, headache, pruritus, insomnia, dizziness, asthenia, and somnolence.

The following adverse reactions occurred in less than 3% of patients involved in clinical trials with oxycodone:

Body as a Whole: abdominal pain, accidental injury, allergic reaction, back pain, chills and fever, fever, flu syndrome, infection, neck pain, pain, photosensitivity reaction, and sepsis.

Cardiovascular: deep vein thrombophlebitis, heart failure, hemorrhage, hypotension, migraine, palpitation, and tachycardia.

Digestive: anorexia, diarrhea, dyspepsia, dysphagia, gingivitis, glossitis, and nausea and vomiting.

Hematopoietic and Lymphatic: anemia and leukopenia.

Metabolism and Nutrition: edema, gout, hyperglycemia, iron deficiency anemia, and peripheral edema.

Musculoskeletal: arthralgia, arthritis, bone pain, myalgia, and pathological fracture.

Nervous System: agitation, anxiety, confusion, dry mouth, hypertonia, hypesthesia, nervousness, neuralgia, personality disorder, tremor, and vasodilation.

Respiratory: bronchitis, cough increased, dyspnea, epistaxis, laryngismus, lung disorder, pharyngitis, rhinitis, and sinusitis.

Skin and Appendages: herpes simplex, rash, sweating, and urticaria.

Special Senses: amblyopia.

Urogenital: urinary tract infection.

Read the entire FDA prescribing information for Oxecta (Oxycodone HCl, USP Tablets)

Related Resources for Oxecta

© Oxecta Patient Information is supplied by Cerner Multum, Inc. and Oxecta Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors